The CDP offers breast cancer tissue microarrays (TMAs) for investigations of marker prevalence associated with progression or prognosis of disease. The Progression tissue microarray is intended for researchers wishing to correlate a marker with staging information or with other markers. The Prognostic tissue microarray is designed to detect associations between tumor markers and clinical outcomes within three stages of breast cancer.
Tissue microarray sections will be cut and shipped after processing fees and shipping charges are paid.
| Charges | ||
|---|---|---|
| Item | Academic Cost | Industry Cost |
| Tissue Microarray sections for progression studies | $1,200/6 sections (replicate sections from 3 case sets) |
$3,600/6 sections (replicate sections from 3 case sets) |
| Tissue Microarray sections for Stage I prognostic studies | $2,000/10 sections (replicate sections from 5 case sets) |
$6,000/10 sections (replicate sections from 5 case sets) |
| Tissue Microarray sections for Stage II prognostic studies | $1,600/8 sections (replicate sections from 4 case sets) |
$4,800/8 sections (replicate sections from 4 case sets) |
| Tissue Microarray sections for Stage III prognostic studies | $800/4 sections (replicate sections from 2 case sets) |
$2,400/4 sections (replicate sections from 2 case sets) |
For additional information, contact:
CDP Tissue Microarray Resources
Information Management Services, Inc.
12501 Prosperity Drive, Suite 200
Silver Spring, MD 20904
Telephone: 301-680-9770
Email: tissueresources@imsweb.com
Please send comments or concerns about this web site to tissueresources@imsweb.com